Expression of the clusterin gene in hematopoietic stem cells marks an age-related shift toward myeloid/platelet over lymphoid cell production In recent years, there has been a growing trend of an ...
Infusions of platelet factor 4 (PF4) have reversed aging in human hematopoietic stem cells (HSCs), the precursors of a range of blood and immune cells. A team from the University of Illinois Chicago ...
Hosted on MSN
Rejuvenating the blood: New pharmacological strategy targets RhoA in hematopoietic stem cells
Aging is defined as the deterioration of function over time, and it is one of the main risk factors for numerous chronic diseases. Although aging is a complex phenomenon affecting the whole organism, ...
Acute graft-versus-host disease (aGVHD) is a life-threatening complication after allogeneic hematopoietic stem cell ...
News-Medical.Net on MSN
Study provides a new paradigm for managing transplant‑related immune complications
Acute graft-versus-host disease (aGVHD) is one of the most serious complications after allogeneic hematopoietic stem cell ...
For people living with multiple sclerosis (MS), the search for effective treatment options can feel like a never-ending journey. While disease-modifying therapies (DMTs) have improved outcomes for ...
The BLA approval is supported by data from the COBLT study, FDA dockets and public information, and from a RegeneCyte observational database. The Food and Drug Administration (FDA) has approved the ...
SCD gene therapy approaches using CRISPR, gene therapy, and base editing show different stem cell outcomes in a mouse study.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback